Phospholipid membrane surfaces on activated platelets (PPM)

Phospholipid membrane surfaces on activated platelets, often referred to as the procoagulant platelet membrane, play a pivotal role in the coagulation cascade by providing a catalytic scaffold for clotting factors. Upon activation by agonists like thrombin or collagen, platelets undergo a loss of membrane asymmetry, resulting in the translocation of anionic phospholipids, primarily phosphatidylserine (PS), from the inner to the outer leaflet of the plasma membrane (Zwaal & Schroit, 1997). This exposed PS surface is essential for the assembly and optimal activity of the tenase and prothrombinase complexes, which accelerate thrombin generation by several orders of magnitude compared to reactions in solution (Heemskerk et al., 2013). In cardiovascular diseases, this surface becomes a primary site for pathological thrombus formation, leading to arterial or venous occlusion (Lentz, 2003). Therapeutic interventions targeting this surface, such as recombinant Annexin A5 or PS-targeting antibodies like Bavituximab, aim to mask the phospholipid scaffold to prevent factor assembly and subsequent fibrin formation (Schutters & Reutelingsperger, 2010). Monitoring these surfaces often involves using PS-binding probes like Annexin V in flow cytometry to assess platelet activation levels and thrombotic risk in patients (Tripodi, 2013).

Other names

Procoagulant platelet membranePhosphatidylserine-exposed platelet surfaceActivated platelet phospholipid surfaceProthrombotic platelet membrane

Inhibition of coagulation factor assembly by binding to and masking exposed anionic phospholipids, primarily phosphatidylserine, thereby preventing the formation of the tenase and prothrombinase complexes.